Joseph J. Whalen
Board Member
Iterum Therapeutics plc (ITRMF)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Joseph J. Whalen
Joseph J. Whalen is recorded as Board Member at Iterum Therapeutics plc (ITRMF). Iterum Therapeutics plc reported in an 8-K filed March 10, 2025 that Joseph J. Whalen was appointed member of the Board, effective March 10, 2025.
“On March 7, 2025, the Board of Directors (the "Board") of Iterum Therapeutics plc (the "Company"), upon recommendation of the nominating and corporate governance committee of the Board, approved the appointment of Joseph J. Whalen as a member of the Board, effective as of March 10, 2025.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
Start not stated–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Iterum Therapeutics plc
Other people whose current roles at this company are on record from its filings.
- Brenton K. Ahrens Chairman
- David Kelly Chairman
- Beth Hecht Board Member
- Beth P. Hecht Board Member
- Corey Fishman Board Member
- David G. Kelly Board Member
- Michael Dunne, M.D. Board Member
- Michael W. Dunne Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.